Pay in 4 interest-free payments of $5.47 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Semaglutide injections can cause a variety of side effects in women
It was also found that 86% of participants in the study were losing more than 5% of their initial body weight
03 Average Procedure Spend: ~$776 per person
US$ 20.90
US$ 20.61
US$ 24.35
US$ 22.46
US$ 20.24
US$ 24.38
US$ 22.48
